Holen Sie sich die Stockscreener-App
4.43
4.73%
-0.22
Finanzdaten der Abeona Therapeutics Inc-Aktie (ABEO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
30.50%
11.38
|
8.72 | 5.42 | - | 0.40 |
| Cost Of Revenue |
54.93%
4.177
|
2.696 | 1.044 | 0.488 | - |
Selling, General, and Administrative
|
18.80%
15.84
|
19.50 | 18.78 | - | - |
| Interest Income/Expense |
16.14%
0.696
|
0.83 | 0.884 | 0.901 | 0.957 |
| Costs And Expenses |
21.16%
25.03
|
31.75 | 28.33 | 24.02 | 23.19 |
| Depreciation and Amortization |
0.00%
0.70
|
0.70 | 0.80 | 0.60 | 0.60 |
| Operating Income/Loss |
40.72%
-13.65
|
-23.03 | -22.91 | -24.02 | -22.79 |
| Nonoperating Income/Loss |
112.00%
-0.006
|
0.05 | 0.051 | 0.129 | 0.089 |
| Income/Loss From Continuing Operations Before Tax |
18.26%
-20.19
|
-17.07 | -20.68 | -20.36 | 124.34 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.002 | -0.215 | -15.20 | 15.51 |
| Net Income/Loss |
18.25%
-20.19
|
-17.07 | -20.46 | -5.161 | 108.83 |
| Basic Average Shares |
0.75%
57.05
|
56.62 | - | 54.24 | 52.52 |
| Diluted Average Shares |
0.75%
57.05
|
56.62 | - | 54.24 | 66.64 |
| Basic Earnings Per Share |
16.67%
-0.35
|
-0.30 | - | -0.10 | 2.07 |
| Diluted Earnings Per Share |
16.67%
-0.35
|
-0.30 | - | -0.10 | 1.71 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):